Antibiotics Market to Exhibit a CAGR of 2.1% by 2027; Rising Incidence of Tuberculosis and Malaria to Spur Lucrative Opportunities, states Fortune Business Insights™
The global “Antibiotics“ market size is expected to reach USD 39.06 billion in 2027
at a CAGR of 2.1% during the forecast period. The increasing R&D for the
development of antimicrobials in multidrug-resistant bacteria is expected to
have a tremendous impact on the global market, states Fortune Business
Insights, in a report, titled “Antibiotics Market Size, Share & Industry
Analysis, By Drug Class (Cephalosporin, Penicillins, Fluoroquinolones,
Macrolides, and Others), By Route of Administration (Oral and Parenteral) By
End User (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and
Regional Forecast, 2020-2027.” The market size stood at USD 43.30 billion in
2019.
Request a Sample Copy of the Research Report :
https://www.fortunebusinessinsights.com/enquiry/sample/antibiotics-market-104583
COVID-19 can
affect the global economy in three main ways: by directly affecting production
and demand, by creating supply chain and market disruption, and by its
financial impact on firms and financial markets. The outbreak of COVID-19 has
brought effects on many aspects, like flight cancellations travel bans and
quarantines restaurants closed all indoor events restricted over forty
countries state of emergency declared massive slowing of the IT Spending market
volatility falling business confidence, growing panic among the population, and
uncertainty about future.
Out research methodology is robust and includes data triangulation
based on bottom-up and top-down approaches. We validated the approximate market
number with the help of primary research. Secondary research was conducted to
find out detailed information about mergers & acquisitions, collaborations,
joint ventures, and agreements. At the same time, we have derived significant
information about the market dynamics associated with growth drivers, trends,
and obstacles.
The report on the antibiotics market discloses:
- Eminent insights into the industry
- Important data with in-depth research
- Factors exhibiting market growth
- Comprehensive study about main regions
- COVID-19 impact on the market
- Prime developments in the industry
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We
understand that this health crisis has brought an unprecedented impact on
businesses across industries. However, this too shall pass. Rising support from
governments and several companies can help in the fight against this highly
contagious disease. There are some industries that are struggling and some are
thriving. Overall, almost every sector is anticipated to be impacted by the
pandemic.
We are taking continuous efforts to help your business sustain and
grow during COVID-19 pandemics. Based on our experience and expertise, we will
offer you an impact analysis of coronavirus outbreak across industries to help
you prepare for the future.
To get to know more about the
short-term and long-term impact of COVID-19 on this market, please visit : https://www.fortunebusinessinsights.com/antibiotics-market-104583
Market Driver:
Increasing Cases of Bacterial Infections to Boost
Market
The increasing cases of bacterial infections will spur demand for
antimicrobials, which, in turn, will augur well for the market. The rising
incidence of tuberculosis, malaria, pneumonia, bacterial skin infections,
urinary tract infections (UTI), and others will bolster the market's healthy
growth during the forecast period. As per the estimates of WHO, the worldwide
prevalence of tuberculosis was 10 million in 2019. According to the Centers for
Disease Control and Prevention, 1.7 million HAIs occur every year in the U.S.,
32% of which are hospital-acquired UTIs. The increasing government efforts to
prevent hospital-acquired infections (HAI), catheter, and ventilator-associated
infections will create lucrative opportunities for the market in the
forthcoming years.
Adoption of Digital Health Technologies to Promote
Growth Amid Coronavirus
The declined patient volume in standalone clinics and hospitals
has forced doctors to adopt digital health technologies to sustain their
business. Pharmaceuticals and medical devices companies have incurred huge
losses due to the economic crisis caused by the pandemic. Moreover, dopped
sales observed by key manufacturers can simultaneously dampen the growth of the
market. For instance, nine months of Pfizer’s Zithromax sales decreased by
14.2% in 2020 compared to 2019. Similarly, Cubicin, manufactured by Merck &
Co., Inc., witnessed a decline of 44.0% in sale during nine months of 2020 as
compared to the previous year
Competitive Landscape:
Substantial R&D Investments by Major Companies to
Consolidate Business
Prominent companies such as Merck & Co., Inc, Sandoz, Taisho
Pharmaceutical Holdings, Daiichi Sankyo Company, Limited are investing in
R&D to strengthen their position in the industry. Moreover, the increasing
approvals for innovative therapies by the FDA can spur lucrative opportunities
for the market. For instance, in August 2019, TB
Alliance, a non-profit organization, received FDA approval for Pretomanid, as
part of combination therapy with linezolid and bedaquiline to treat TB.
Quick Buy Antibiotics Market
Report Research : https://www.fortunebusinessinsights.com/checkout-page/104583
Regional Analysis:
Heavy Demand for Antibiotics to Contribute Growth in
Asia Pacific
The market in Asia Pacific is expected to hold the largest share
during the forecast period due to the high consumption of antibiotics.
According to an article published in the journal Proceedings of the National
Academy of Sciences of the United States of America (PNAS), China, India, and
Pakistan witnessed a rise of 103%, 79%, and 69%, respectively, in antibiotic
consumption during 2000-2015. The growing prevalence of bacterial infections
coupled with the high use of antimicrobials will spur lucrative opportunities
for the Asia Pacific market.
Key Development:
January 2020: Wockhardt announced that it had received approval from The Drug
Controller General of India (DCGI) for Emrok (injectable) and Emrok O (oral) in
acute bacterial skin and skin structure infections, including diabetic foot
infections.
The Report Lists the Key Players in
the Antibiotics Market:
- Pfizer Inc. (New York, U.S.)
- GlaxoSmithKline plc (Brentford, U.K.)
- Merck & Co., Inc. (New Jersey, U.S.)
- Sandoz (Novartis AG) (Holzkirchen, Germany)
- Daiichi Sankyo Company, Limited (Tokyo, Japan)
- Taisho Pharmaceutical Holdings (Tokyo, Japan)
- Melinta Therapeutics (New Jersey, U.S.)
- Other Prominent Players
Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/antibiotics-market-104583
Table of Content
Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
Executive Summary
Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
Key Insights
- Prevalence of Key Bacterial Infections– For Key Countries/
Regions
- Antimicrobial Resistance Statistics – For Key Countries/
Regions
- Pipeline Snapshot
- New Product Launches
- Key Industry Developments – Partnerships, Mergers, &
Acquisitions
- Impact of COVID-19 Pandemic on Antibiotics Market
Global Antibiotics Market Analysis, Insights and
Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- Cephalosporin
- Penicillins
- Fluoroquinolones
- Macrolides
- Others
- Market Analysis, Insights and Forecast – By Route of
Administration
- Oral
- Parenteral
- Market Analysis, Insights and Forecast – By Distribution
Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Related Reports:
About Us:
Fortune Business Insights™ offers expert corporate analysis and
accurate data, helping organizations of all sizes make timely decisions. We
tailor innovative solutions for our clients, assisting them to address
challenges distinct to their businesses. Our goal is to empower our clients
with holistic market intelligence, giving a granular overview of the market
they are operating in.
Our reports contain a unique mix of tangible insights and
qualitative analysis to help companies achieve sustainable growth. Our team of
experienced analysts and consultants use industry-leading research tools and
techniques to compile comprehensive market studies, interspersed with relevant
data.
At Fortune Business Insights™ we aim at highlighting the most
lucrative growth opportunities for our clients. We, therefore, offer
recommendations, making it easier for them to navigate through technological
and market-related changes. Our consulting services are designed to help
organizations identify hidden opportunities and understand prevailing
competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Comments
Post a Comment